Medication Related OsteoNecrosis of the Jaws (MRONJ) is a serious complication of antiresorptive treatment with bisphosphonates and denosumab and/or tyrosine kinase inhibitors meant to reduce unwanted skeletal events for patients with bone metastases from cancer as well as osteoporosis patients. MRONJ can lead to chronic pain, infection, tooth loss, impaired chewing function and can notably reduce the quality of life of the affected individuals.
We have gathered ten European experts on MRONJ, who are highly recognized clinicians and scientists from Germany, Italy, England, Greece, Switzerland, Norway and Denmark with notable track records of research and scientific publications in the field. Based on the most recent evidence, these experts will provide an update for dentists, clinicians, OMF Surgeons and other specialists on classification, clinical manifestations, treatment, pathogenesis and prevention of MRONJ.
Furthermore the speakers will deal with burning questions regarding patient diagnosis and management, and patient cases will be presented for general discussion. The symposium is aimed at dentists, maxillofacial surgeons, oral medicine physicians, other specialists and all clinicians, as well as residents and students who have an interest or manage patients with MRONJ.
Please email the organiser regarding registration including your name, country of residence and current position (dentist / student / other). You will then receive a confirmation with a link to payment.